Sunovion Pharmaceuticals Inc. To Present New Data On Aptiom® (eslicarbazepine acetate) At The American Epilepsy Society’s 67th Annual Meeting
Published: Dec 09, 2013
Sunovion Pharmaceuticals Inc. (Sunovion) will present new research posters on Aptiom® (eslicarbazepine acetate) and data on antiepileptic drug (AED) use in the U.S. managed care population at the 67th Annual Meeting of the American Epilepsy Society (AES) taking place December 6-10 in Washington, D.C.
Help employers find you! Check out all the jobs and post your resume.